TCL Archive Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said. October 14, 2005
TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock December 17, 2013
TCL Archive In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div. February 28, 1992